Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15136498 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Darusentan Effect on PET Uptake Heterogeneity
Conditions: Coronary Artery Disease;   Endothelial Dysfunction
Intervention: Drug: darusentan 100 mg

Indicates status has not been verified in more than two years